Cited by 152Chemokine receptors and signalingTGF-β signaling in diseasesImmunotherapy and Immune Responses

TGF-β1 Reciprocally Controls Chemotaxis of Human Peripheral Blood Monocyte-Derived Dendritic Cells Via Chemokine Receptors

Open access
Sato, Katsuaki, Kawasaki, Hiroshi, Nagayama, Hitomi, Enomoto, Makoto, Morimoto, Chikao, Tadokoro, Kenji, Juji, Takeo, Takahashi, Tsuneo A·2000·The Journal of Immunology

Abstract

We examined the effect of TGF-β1 on the chemotactic migratory ability of human monocyte-derived dendritic cells (DCs). Treatment of immature DCs with TGF-β1 resulted in increased expressions of CCR-1, CCR-3, CCR-5, CCR-6, and CXC chemokine receptor-4 (CXCR-4), which were concomitant with enhanced chemotactic migratory responses to their ligands, RANTES (for CCR-1, CCR-3, and CCR-5), macrophage-inflammatory protein-3α (MIP-3α) (for CCR-6), or stromal cell-derived growth factor-1α (for CXCR-4). Ligation by TNF-α resulted in down-modulation of cell surface expressions of CCR-1, CCR-3, CCR-5, CCR-6, and CXCR-4, and the chemotaxis for RANTES, MIP-3α, and stromal cell-derived growth factor-1α, whereas this stimulation up-regulated the expression of CCR-7 and the chemotactic ability for MIP-3β. Stimulation of mature DCs with TGF-β1 also enhanced TNF-α-induced down-regulation of the expressions of CCR-1, CCR-3, CCR-5, CCR-6, and CXCR-4, and chemotaxis to their respective ligands, while this stimulation suppressed TNF-α-induced expression of CCR-7 and chemotactic migratory ability to MIP-3β. Our findings suggest that TGF-β1 reversibly regulates chemotaxis of DCs via regulation of chemokine receptor expression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.164.5.2285

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dendritic cells in the intestine can promote regulatory T cell development via TGF-β activation, perhaps through integrin αvβ8.

    “Additionally, intestinal DCs can induce Treg cell differentiation through activation of TGF-β, possibly involving cell-intrinsic expression of integrin αvβ8186,187.”

    From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [187]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Lee, W.-C., C. Zhong, S. Qian, Y. Wan, J. Gauldie, Z. Mi, P. D. Robbins, A. W. Thomson, and L. Lu. 1998. Phenotype, function and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineering to ex- press TGF-␤. Transplantation 66:1810.

Cited by

Sorted by citations

Authors
Sato, K., Kawasaki, H., Nagayama, H., Enomoto, M., Morimoto, C., Tadokoro, K., Juji, T., & Takahashi, T. A.
Affiliations
  • Institute of Medical Science, The University of Tokyo (JP)
  • Japanese Red Cross Society, Japan (JP)
Corresponding author
  • Sato, Katsuaki
  • Nagayama, Hitomi
  • Enomoto, Makoto
Venue
The Journal of Immunology
Published
2000-03-01
Volume
164
Issue
5
Pages
2285-2295
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1483423516
Cited by
152
References
53
Citations by year
2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 4 · 2013: 5 · 2012: 9
FWCI
5.73
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
TGF-β1, dendritic cells, monocyte-derived dendritic cells, chemotaxis, chemokine receptors, CCR5, CXCR4, RANTES, TNF-α, dendritic cell maturation, receptor down-regulation
MeSH terms
Cell Differentiation, Cell Membrane, Cells, Cultured, Chemotaxis, Leukocyte, Dendritic Cells, Humans, Ligands, Monocytes, Tumor Necrosis Factor-alpha, Down-Regulation, Up-Regulation, Immunophenotyping, Transforming Growth Factor beta, Interleukin-10, Macrophage Inflammatory Proteins, Receptors, Chemokine, Receptors, CCR5, Receptors, CXCR4, Chemokines, CC, Receptors, CCR1, Receptors, CCR3, Receptors, CCR6, Receptors, CCR7, Chemokine CCL19, Chemokine CCL20, CCR5 Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review